Showing 61 - 71 of 71 results
In CoreSource v. Quality Healthcare Intermediary, submitted declarations to US Patent Trial and Appeals Board on behalf of the petitioner in a patent infringement matter involving methods for optimizing healthcare services management ...
Conducted detailed economic analysis on behalf of Eli Lilly in connection with its $5.4 billion acquisition of Novartis Animal Health. Both firms were active in developing and marketing animal health products, including medications used to ...
Supported the expert working on behalf of Thermo Fisher Scientific in evaluating the likely competitive effects of its proposed $13.6 billion acquisition of Life Technologies; both firms provide analytical and laboratory services and ...
With support from Bates White, pharmaceutical manufacturer Amgen Inc. settled litigation with Teva Pharmaceuticals USA Inc. concerning Teva’s challenge to the validity of Amgen’s patents for Neupogen. The client obtained a favorable ...
In October 2012, McKesson Corporation (McKesson), a healthcare services and information technology company, announced an agreement to purchase PSS World Medical Inc., a distributor of medical products and services, in a transaction valued ...
Pharmacy benefits manager Express Scripts completed its $29 billion acquisition of Medco Health Solutions after the Federal Trade Commission closed its eight month investigation of the proposed acquisition. Bates White supported Skadden ...
Served as testifying expert on behalf of Augustine Medical, Inc. defending an illegal monopolization counterclaim in Augustine Medical, Inc. v. Mallinckrodt, Inc. Responsibilities included assisting the expert in analyses of market ...
In Applied Medical v. Ethicon Endo-Surgery, on behalf of Applied Medical, investigated economic issues associated with the Court’s consideration of injunctive relief concerning allegations of false advertising in markets for ...
Evaluated the net benefits associated with granting patent term restoration for a brand-name pharmaceutical for which the US Patent and Trademark Office did not grant such extension. Work resulted in a white paper that updated a previous CBO ...
Provided analysis on behalf of Grifols in connection with its acquisition of Talecris, both companies involved in the manufacture and sale of plasma-derived therapies used to treat a range of medical conditions. Evaluated possible ...
Testified on behalf of UnitedHealth, assessed damages in a lawsuit alleging that premerger coordination led to the joint exercise of monopsony power. Omnicare, a supplier of institutional pharmacy services, filed a lawsuit against ...